project id: TCGA-LUAD; case submitter id: TCGA-75-5125; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; days to death: 2027; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.7; longest dimension: 1.6; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-75-5125-01A-01; percent necrosis: 5.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 80.0;